CCL14 and hepatocellular carcinoma: Since some of the current HCC immunohistochemistry biomarkers, like CCL14 and CK19, frequently result in inaccurate staining, EWSR1 has been proposed to be used as a nuclear staining biomarker for HCC for more conclusive results [142].